Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-03-17
1999-08-03
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 95, A61K 31535, C07D49800
Patent
active
059325739
ABSTRACT:
The present invention relates to novel substituted quinolines and isoquinolines and derivatives thereof useful in the treatment of neurological disorders. Methods of preparing the compounds, intermediates useful in the preparation and pharmaceutical compositions containing the compounds are also included. The compounds are useful in treating pain, cerebral ischemia, and other cerebrovascular disorders.
REFERENCES:
Bowersox, et al., "Neuronal Voltage-Sensitive Calcium Channels", Drug News and Perspective, 7(5):261-268 (1994).
Yamada, et al., Chemical Abstract 96:85389p.
Shterev and Kaneti, Chemical Abstract 108:142832v.
Bourquin, et al., "Synthese von Estern halogenierter Chinaldine und Chinoline", Archiv der Pharmazie, 295(5):383-400 (1962).
Brack, "Antimikrobielle Wirkung von 8-Hydroxychinolin-Derivaten, besonders von einigen neuen Estern", Arzneimittel-Forsch. 12, 133-144 (1962).
Anderson Elizabeth M.
Kifle Bruck
Shah Mukund J.
Warner-Lambert & Company
LandOfFree
Substituted quinolines and isoquinolines as calcium channel bloc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinolines and isoquinolines as calcium channel bloc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinolines and isoquinolines as calcium channel bloc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849663